Inflammation and the heart - prime time for new therapeutic approaches
- PMID: 23790157
- DOI: 10.1517/14728214.2013.811487
Inflammation and the heart - prime time for new therapeutic approaches
Abstract
Introduction: Atherosclerosis remains one of the main causes of cardiovascular disease.
Areas covered: A brief overview of the work summarized by Berman et al. [Berman JP, Farkouh ME, Rosenson RS. Emerging anti-inflammatory drugs for atherosclerosis. Expert Opin Emerg Drugs 2013;18(2):193-205] on the development of anti-inflammatory drugs to tackle atherosclerosis is provided.
Expert opinion: Indeed, recent data from clinical trials on anti-inflammatory drugs in coronary artery disease highlight the potential of such therapies.
Comment on
-
Emerging anti-inflammatory drugs for atherosclerosis.Expert Opin Emerg Drugs. 2013 Jun;18(2):193-205. doi: 10.1517/14728214.2013.801453. Epub 2013 May 16. Expert Opin Emerg Drugs. 2013. PMID: 23675745 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical